Cargando…
Androgens, aging, and prostate health
Due to late onset hypogonadism (LOH), there is an increased usage of testosterone replacement therapy (TRT) in the aging male population. Since prostate is a target organ for androgens and anti-androgenic strategies are used to treat and palliate benign prostate hyperplasia (BPH) and prostate cancer...
Autores principales: | Welén, Karin, Damber, Jan-Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789017/ https://www.ncbi.nlm.nih.gov/pubmed/35748976 http://dx.doi.org/10.1007/s11154-022-09730-z |
Ejemplares similares
-
Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies
por: Hagberg Thulin, Malin, et al.
Publicado: (2013) -
Gene Expression Alterations during Development of Castration-Resistant Prostate Cancer Are Detected in Circulating Tumor Cells
por: Josefsson, Andreas, et al.
Publicado: (2019) -
Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression
por: Linder, Anna, et al.
Publicado: (2018) -
Osteoclasts directly influence castration-resistant prostate cancer cells
por: Huang, Junchi, et al.
Publicado: (2022) -
ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors
por: Gustavsson, Heléne, et al.
Publicado: (2010)